Table 3.
Hydrogel-based biomaterials for controlled drug delivery.
| Type | Polymer | Drug delivered | Drug type | Mode of release | Reference |
|---|---|---|---|---|---|
| Natural hydrogels | Alginate | VEGF | Protein | Diffusive | Silva and Mooney (2007, 2010) |
| Alginate | VEGF and PDGF | Dual proteins | Diffusive | Sylven et al. (2007) | |
| Fibrin | VEGF | Protein | Proteolytic degradation | Ehrbar et al. (2004) | |
| Extracellular matrix | bFGF | Protein | sGAG-binding affinity | Seif-Naraghi et al. (2012) | |
| Extracellular matrix | HGF-f | Protein fragment | sGAG-binding affinity | Sonnenberg et al. (2015) | |
| Gelatin | FGF-2 and G-CSF | Dual proteins | Diffusive and ionic interactions | Layman et al. (2009) | |
| Hyaluronic acid | TGF-β1 | Protein | Heparin-binding affinity | Jha et al. (2015) | |
| Matrigel | T7 Vasculotide | PEG-peptide tetramer | Diffusive | Van Slyke et al. (2009) | |
| Matrigel | Qk | Peptide | Diffusive | Santulli et al. (2009) | |
| Synthetic hydrogels | Poly(ethylene glycol) multiacrylate and dithiolthreitol | hGH | Protein | Dissolution and diffusion | van de Wetering et al. (2005) |
| Poly(ethylene glycol vinyl sulfone and proteolytically cleavable peptide | VEGF | Protein | Enzymatically responsive | Zisch et al. (2003) | |
| Poly(ethylene glycol) diacrylate and proteolytically cleavable peptide | VEGF | Protein | Enzymatically responsive | Phelps et al. (2010) | |
| Poly(ethylene glycol) norbornene and enzymatically cleavable peptide | Qk, SPARC113, SPARC118, and model peptides | Peptide | Enzymatically responsive | Van Hove et al. (2014) | |
| Poly(N-isopropylacrylamide-co-propylacrylic acid-co-butyl acrylate) | bFGF | Protein | pH-responsive and diffusive | Garbern et al. (2010), Murry et al. (2011) | |
| Combinatory/hybrid hydrogels | Poly(ethylene glycol)-bis-butanoic acid and hydrazide-functionalized heparin | VEGF | Protein | Heparin-binding affinity | Tae et al. (2006) |
| Multi-arm poly(ethylene glycol) thiol and dextran vinyl sulfone | IgG, BSA, Lysozyme, and bFGF | Protein | Diffusive | Hiemstra et al. (2007) | |
| Poly(ether)urethane–polydimethylsiloxane + fibrin | VEGF and bFGF | Dual proteins | Diffusive | Losi et al. (2010) | |
| Hyaluronic acid + PEG | VEGF and bFGF | Protein | Heparin-binding affinity | Pike et al. (2006) |
Select examples of hydrogel-based biomaterials used for controlled drug delivery.